These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

221 related articles for article (PubMed ID: 23857366)

  • 1. FCRL3 promotes TLR9-induced B-cell activation and suppresses plasma cell differentiation.
    Li FJ; Schreeder DM; Li R; Wu J; Davis RS
    Eur J Immunol; 2013 Nov; 43(11):2980-92. PubMed ID: 23857366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. IFN-alpha amplifies human naive B cell TLR-9-mediated activation and Ig production.
    Giordani L; Sanchez M; Libri I; Quaranta MG; Mattioli B; Viora M
    J Leukoc Biol; 2009 Aug; 86(2):261-71. PubMed ID: 19401392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Amplification of Toll-like receptor-mediated signaling through spleen tyrosine kinase in human B-cell activation.
    Iwata S; Yamaoka K; Niiro H; Nakano K; Wang SP; Akashi K; Tanaka Y
    J Allergy Clin Immunol; 2012 Jun; 129(6):1594-601.e2. PubMed ID: 22541243
    [TBL] [Abstract][Full Text] [Related]  

  • 4. TLR9/FCRL3 regulates B cell viability, apoptosis, and antibody and IL-10 production through ERK1/2, p38, and STAT3 signaling pathways.
    Liu QB; Zhou RH; Liu CM
    In Vitro Cell Dev Biol Anim; 2022 Sep; 58(8):702-711. PubMed ID: 36121575
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Ras participates in CpG oligodeoxynucleotide signaling through association with toll-like receptor 9 and promotion of interleukin-1 receptor-associated kinase/tumor necrosis factor receptor-associated factor 6 complex formation in macrophages.
    Xu H; An H; Yu Y; Zhang M; Qi R; Cao X
    J Biol Chem; 2003 Sep; 278(38):36334-40. PubMed ID: 12867418
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CpG DNA induces IgG class switch DNA recombination by activating human B cells through an innate pathway that requires TLR9 and cooperates with IL-10.
    He B; Qiao X; Cerutti A
    J Immunol; 2004 Oct; 173(7):4479-91. PubMed ID: 15383579
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGFβ activated kinase 1 (TAK1) at the crossroad of B cell receptor and Toll-like receptor 9 signaling pathways in human B cells.
    Szili D; Bankó Z; Tóth EA; Nagy G; Rojkovich B; Gáti T; Simon M; Hérincs Z; Sármay G
    PLoS One; 2014; 9(5):e96381. PubMed ID: 24801688
    [TBL] [Abstract][Full Text] [Related]  

  • 8. TLR7- and TLR9-responsive human B cells share phenotypic and genetic characteristics.
    Simchoni N; Cunningham-Rundles C
    J Immunol; 2015 Apr; 194(7):3035-44. PubMed ID: 25740945
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of human B cell activation by TLR7 and TLR9 agonists.
    Hanten JA; Vasilakos JP; Riter CL; Neys L; Lipson KE; Alkan SS; Birmachu W
    BMC Immunol; 2008 Jul; 9():39. PubMed ID: 18652679
    [TBL] [Abstract][Full Text] [Related]  

  • 10. TLR9 Signaling Suppresses the Canonical Plasma Cell Differentiation Program in Follicular B Cells.
    Baptista BJA; Granato A; Canto FB; Montalvão F; Tostes L; de Matos Guedes HL; Coutinho A; Bellio M; Vale AM; Nobrega A
    Front Immunol; 2018; 9():2281. PubMed ID: 30546358
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Syk is indispensable for CpG-induced activation and differentiation of human B cells.
    Kremlitzka M; Mácsik-Valent B; Erdei A
    Cell Mol Life Sci; 2015 Jun; 72(11):2223-36. PubMed ID: 25543269
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Cell-intrinsic expression of TLR9 in autoreactive B cells constrains BCR/TLR7-dependent responses.
    Nündel K; Green NM; Shaffer AL; Moody KL; Busto P; Eilat D; Miyake K; Oropallo MA; Cancro MP; Marshak-Rothstein A
    J Immunol; 2015 Mar; 194(6):2504-12. PubMed ID: 25681333
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Interleukin-1 receptor-associated kinase-1 plays an essential role for Toll-like receptor (TLR)7- and TLR9-mediated interferon-{alpha} induction.
    Uematsu S; Sato S; Yamamoto M; Hirotani T; Kato H; Takeshita F; Matsuda M; Coban C; Ishii KJ; Kawai T; Takeuchi O; Akira S
    J Exp Med; 2005 Mar; 201(6):915-23. PubMed ID: 15767370
    [TBL] [Abstract][Full Text] [Related]  

  • 14. FCRL3, an autoimmune susceptibility gene, has inhibitory potential on B-cell receptor-mediated signaling.
    Kochi Y; Myouzen K; Yamada R; Suzuki A; Kurosaki T; Nakamura Y; Yamamoto K
    J Immunol; 2009 Nov; 183(9):5502-10. PubMed ID: 19843936
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of the autoimmune susceptibility gene FcRL3 on human regulatory T cells is associated with dysfunction and high levels of programmed cell death-1.
    Swainson LA; Mold JE; Bajpai UD; McCune JM
    J Immunol; 2010 Apr; 184(7):3639-47. PubMed ID: 20190142
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DOCK8 functions as an adaptor that links TLR-MyD88 signaling to B cell activation.
    Jabara HH; McDonald DR; Janssen E; Massaad MJ; Ramesh N; Borzutzky A; Rauter I; Benson H; Schneider L; Baxi S; Recher M; Notarangelo LD; Wakim R; Dbaibo G; Dasouki M; Al-Herz W; Barlan I; Baris S; Kutukculer N; Ochs HD; Plebani A; Kanariou M; Lefranc G; Reisli I; Fitzgerald KA; Golenbock D; Manis J; Keles S; Ceja R; Chatila TA; Geha RS
    Nat Immunol; 2012 May; 13(6):612-20. PubMed ID: 22581261
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Augmented TLR9-induced Btk activation in PIR-B-deficient B-1 cells provokes excessive autoantibody production and autoimmunity.
    Kubo T; Uchida Y; Watanabe Y; Abe M; Nakamura A; Ono M; Akira S; Takai T
    J Exp Med; 2009 Aug; 206(9):1971-82. PubMed ID: 19687229
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Toll-like receptor agonists induce apoptosis in mouse B-cell lymphoma cells by altering NF-κB activation.
    Arunkumar N; Liu C; Hang H; Song W
    Cell Mol Immunol; 2013 Jul; 10(4):360-72. PubMed ID: 23727784
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Suppression of B-cell activation and IgE, IgA, IgG1 and IgG4 production by mammalian telomeric oligonucleotides.
    Sackesen C; van de Veen W; Akdis M; Soyer O; Zumkehr J; Ruckert B; Stanic B; Kalaycı O; Alkan SS; Gursel I; Akdis CA
    Allergy; 2013; 68(5):593-603. PubMed ID: 23480796
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Stimulation and inhibition of FVIII-specific memory B-cell responses by CpG-B (ODN 1826), a ligand for Toll-like receptor 9.
    Allacher P; Baumgartner CK; Pordes AG; Ahmad RU; Schwarz HP; Reipert BM
    Blood; 2011 Jan; 117(1):259-67. PubMed ID: 20889922
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.